2010
DOI: 10.1002/ijc.25615
|View full text |Cite
|
Sign up to set email alerts
|

Aging‐related alterations in the extracellular matrix modulate the microenvironment and influence tumor progression

Abstract: Age is the greatest risk factor for the development of epithelial cancers. In this minireview, we will examine key extracellular matrix and matricellular components, their changes with aging, and discuss how these alterations might influence the subsequent progression of cancer in the aged host. Because of the tight correlation between advanced age and the prevalence of prostate cancer, we will use prostate cancer as the model throughout this minireview.Most tissues undergo significant modification with age. F… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
64
0

Year Published

2012
2012
2024
2024

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 74 publications
(64 citation statements)
references
References 116 publications
(177 reference statements)
0
64
0
Order By: Relevance
“…During carcinogenesis elevated levels of proteases, including matrix metalloproteinases (MMPs), are produced by tumor and/or stromal cells which are currently thought to endow cells with invasive properties (Fülöp and Larbi, 2002). These MMPs are able to degrade a variety of ECM molecules such as type IV collagen, elastin, laminina (Fülöp and Larbi, 2002) and type I collagen, in normal physiological processes and pathological stages (Roy et al, 2009;Hatfield et al, 2010;Sprenger et al, 2010). They are secreted as pro-enzymes and have to be activated by partial proteolytic cleavage to become biologically active, mainly by plasminogen activator.…”
Section: Metalloproteinasesmentioning
confidence: 99%
“…During carcinogenesis elevated levels of proteases, including matrix metalloproteinases (MMPs), are produced by tumor and/or stromal cells which are currently thought to endow cells with invasive properties (Fülöp and Larbi, 2002). These MMPs are able to degrade a variety of ECM molecules such as type IV collagen, elastin, laminina (Fülöp and Larbi, 2002) and type I collagen, in normal physiological processes and pathological stages (Roy et al, 2009;Hatfield et al, 2010;Sprenger et al, 2010). They are secreted as pro-enzymes and have to be activated by partial proteolytic cleavage to become biologically active, mainly by plasminogen activator.…”
Section: Metalloproteinasesmentioning
confidence: 99%
“…Furthermore, there is a strong correlation between some types of cancer occurrence and age progression (Henry et al, 2011;Sprenger et al, 2010). Accumulation of DNA damage and mutations as a result of impaired DNA repair mechanisms can lead to neoplastic transformation (Helleday, 2011).…”
Section: Discussionmentioning
confidence: 99%
“…[19][20][21][22][23] In conjunction with these critical drivers of carcinogenesis, other factors related to the etiopathogenesis of cancer involve energy metabolism [24][25][26] and evasion of the immune surveillance system. [27][28][29] When cancer spread and metastasis occur, the 'tumor microenvironment' in the bone of PCa patients may allow cells to remain dormant or senescent and eventually allow the establishment of a 'seed and soil' site where PCa proliferation and growth may occur over time. 29,30 These molecular alterations can be evaluated with a variety of protocols that detect the numerous changes in chromosome structure and organization in cancer and other diseases.…”
Section: Nuclear Morphometry Nucleomics and Prostate Cancer Progressionmentioning
confidence: 99%
“…[27][28][29] When cancer spread and metastasis occur, the 'tumor microenvironment' in the bone of PCa patients may allow cells to remain dormant or senescent and eventually allow the establishment of a 'seed and soil' site where PCa proliferation and growth may occur over time. 29,30 These molecular alterations can be evaluated with a variety of protocols that detect the numerous changes in chromosome structure and organization in cancer and other diseases. These protocols include nucleic acid sequencing, real-time PCR, methylation-specific qRT-PCR, comparative genomic hybridization, chromosome staining, fluorescence in situ hybridization, genotyping and cloning.…”
Section: Nuclear Morphometry Nucleomics and Prostate Cancer Progressionmentioning
confidence: 99%